AU596642B2 - Molecular probes, process for preparation thereof, and applications including their use for determining the sex of embryos - Google Patents
Molecular probes, process for preparation thereof, and applications including their use for determining the sex of embryos Download PDFInfo
- Publication number
- AU596642B2 AU596642B2 AU69203/87A AU6920387A AU596642B2 AU 596642 B2 AU596642 B2 AU 596642B2 AU 69203/87 A AU69203/87 A AU 69203/87A AU 6920387 A AU6920387 A AU 6920387A AU 596642 B2 AU596642 B2 AU 596642B2
- Authority
- AU
- Australia
- Prior art keywords
- dna
- probe
- hybridization
- spermatozoa
- ruminants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 90
- 230000008569 process Effects 0.000 title claims description 44
- 239000003068 molecular probe Substances 0.000 title claims description 34
- 210000002257 embryonic structure Anatomy 0.000 title claims description 19
- 238000002360 preparation method Methods 0.000 title claims description 15
- 108020004414 DNA Proteins 0.000 claims description 163
- 239000000523 sample Substances 0.000 claims description 73
- 238000009396 hybridization Methods 0.000 claims description 56
- 241000282849 Ruminantia Species 0.000 claims description 46
- 210000004027 cell Anatomy 0.000 claims description 45
- 210000002593 Y chromosome Anatomy 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 35
- 241000283690 Bos taurus Species 0.000 claims description 33
- 239000012634 fragment Substances 0.000 claims description 32
- 239000013612 plasmid Substances 0.000 claims description 24
- 241000283725 Bos Species 0.000 claims description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000872 buffer Substances 0.000 claims description 20
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 19
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 18
- 108091034117 Oligonucleotide Proteins 0.000 claims description 17
- 239000000499 gel Substances 0.000 claims description 17
- 238000007901 in situ hybridization Methods 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 13
- 230000029087 digestion Effects 0.000 claims description 12
- 238000001962 electrophoresis Methods 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 238000002372 labelling Methods 0.000 claims description 11
- 239000011543 agarose gel Substances 0.000 claims description 10
- 210000004698 lymphocyte Anatomy 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- 239000002609 medium Substances 0.000 claims description 9
- 230000002285 radioactive effect Effects 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000000376 autoradiography Methods 0.000 claims description 6
- 210000003754 fetus Anatomy 0.000 claims description 6
- 210000001161 mammalian embryo Anatomy 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 108010042407 Endonucleases Proteins 0.000 claims description 4
- 102000004533 Endonucleases Human genes 0.000 claims description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 4
- 238000001574 biopsy Methods 0.000 claims description 4
- 238000011065 in-situ storage Methods 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 210000004940 nucleus Anatomy 0.000 claims description 4
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 230000035939 shock Effects 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 4
- 238000000527 sonication Methods 0.000 claims description 4
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 claims description 3
- 102000053602 DNA Human genes 0.000 claims description 3
- 101000892431 Proteus hauseri Type II restriction enzyme PvuII Proteins 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 229960000723 ampicillin Drugs 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 230000016507 interphase Effects 0.000 claims description 3
- 230000031864 metaphase Effects 0.000 claims description 3
- 238000013508 migration Methods 0.000 claims description 3
- 230000005012 migration Effects 0.000 claims description 3
- 150000008300 phosphoramidites Chemical class 0.000 claims description 3
- 230000002797 proteolythic effect Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 229940023064 escherichia coli Drugs 0.000 claims 2
- 239000005030 aluminium foil Substances 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 239000006152 selective media Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 32
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 11
- 210000001766 X chromosome Anatomy 0.000 description 11
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 235000020183 skimmed milk Nutrition 0.000 description 10
- 238000011534 incubation Methods 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 8
- 229910052709 silver Inorganic materials 0.000 description 8
- 239000004332 silver Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 102000020897 Formins Human genes 0.000 description 7
- 108091022623 Formins Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 239000001509 sodium citrate Substances 0.000 description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000004163 cytometry Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 5
- 108010067770 Endopeptidase K Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229920005654 Sephadex Polymers 0.000 description 5
- 239000012507 Sephadex™ Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 102000013415 peroxidase activity proteins Human genes 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000020509 sex determination Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000972773 Aulopiformes Species 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000001745 anti-biotin effect Effects 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 229960000633 dextran sulfate Drugs 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000009027 insemination Effects 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000002985 plastic film Substances 0.000 description 4
- 229920006255 plastic film Polymers 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 235000019515 salmon Nutrition 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 239000010902 straw Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241001529936 Murinae Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 108091006629 SLC13A2 Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 210000004381 amniotic fluid Anatomy 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001182 human Y chromosome Anatomy 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 3
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229960002086 dextran Drugs 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 150000003378 silver Chemical class 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
- 108010047524 Deoxyribonuclease HindIII Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 108010034791 Heterochromatin Proteins 0.000 description 1
- 238000010867 Hoechst staining Methods 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 101500006448 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) Endonuclease PI-MboI Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 210000004458 heterochromatin Anatomy 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003765 sex chromosome Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 231100000081 spermatotoxicity Toxicity 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Description
i i. ii ~4:4 ?r d~.
i
AUSTRALIA
596642 Form PATENTS ACT 1952 COMPLETE SPECIFICATION
(ORIGINAL)
FOR OFFICE USE Short Title: Int. Cl: Application Number: A 1 0OS/j7, Lodged: Complete Specification-Lodged: Accepted: Lapsed: Published: 7li Ih~ Priority: Related Art: TO BE COMPLETED BY APPLICANT Name of Applicant: il *r I 1) INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) 2) INSTITUT PASTEUR 3) COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA) Address of Applicant: 1) 149 RUE DE GRENELLE, 75007 PARIS, FRANCE 2) 28 RUE DU DR ROUX, 75724 PARIS CEDEX
FRANCE
3) 29-33 RUE DE LA FEDERATION, 75015 PARIS,
FRANCE
Actual Inventor: Address for Service: CLEMENT HACK CO., 601 St. Kilda Road, Melbourne, Victoria 3004, Australia. I" Complete Specification for the invention entitled: MOLECULAR PROBES, PROCESS FOR PREPARATION THEREOF, AND APPLICATIONS INCLUDING THEIR USE FOR DETERMINING THE SEX OF EMBRYOS The following statement is a full description of this invention including the best method of performing it known to me:i i i- -ia The present invention relates to the preparation of molecular probes for specific DNA which are useful for determining the sex of ruminant embryos or fetuses, especially of the subfamily of the bovines, and particularly of the genus Bos, exhibiting sequences of DNA specific for the male sex.
Determination of the sex of embryos and fetuses is of great interest in several respects. Determination of the sex of human embryos permits early detection of serious genetic diseases linked to the sex of the embryo.
Determination of the sex of livestock embryos, on the other hand, is of great economic interest.
Sex (male or female) is known to be determined by the sex chromosomes. In mammals, the presence of a Y chromosome is sufficient to produce a male phenotype and it seems that the sex-determining genes present on the Y chromosome behave like a dominant genetic trait.
6° °o The first step towards early determLnation of o o the sex of human embryos therefore consisted of a o ~Qo chromosomal analysis of cultured cells of amniotic fluid.
However, as this type of analysis takes two to three weeks, it was found necessary to provide other methods for early determination of the sex of embryos, which were capable of giving quicker results.
It was established that not all the Y chromosome was involved in sexual differentiation. It therefore Oda* seemed logical to analyze the sequences present on the Y chromosome and the first step in this direction con- S sisted in isolating and cloning the DNA of the Y chromosome.
a, ftf ft f ft f eq ft ft ft f 4 ftC Thus, KUNKEL et al. (especially in BIOCHEM., vol. 18, no. 15, p. 3343-3353, 1979) isolated fragments of 3.4 kilobases (kb) of human male DNA by coupling with the aid of restriction endonucleases such as HaeIII, EcoRI or EcoRII and showed that the repetitious DNA specific for the Y chromosome (DNA Y-it) was present in 2 these 3.4 kb molecules. However, although the work of KUNKEL et al. provides valuable information on the organization of two types of repetitive sequences respectively specific and non-specific for the Y chromosome in each 3.4 kb molecule, it cannot be used directly in sex determination.
The work of BISHOP et al. (NATURE, vol. 303, June 1983, p. 831-832) was aimed at building a partial library of the Y chromosome using a somatic cell hybrid containing only the human Y chromosome on a murine base, the said hybrid being obtained by the fusion of male human lymphocytes with the murine cell line RAG and containing a modal number of four human Y chromosomes per cell; the authors extracted highmolecular DNA from the hybrid, carried out a partial digestion with the aid of the restriction enzyme MboI 0, 0 and cloned the 35-50 kb fragments in Escherichia coli bacteria using the cosmid pJB8. To differentiate the ooo clones containing human DNA inserts (derived from Y) 20 from those containing murine DNA, the colonies were tested at low density with 32-labeled repetitious human DNA with a view to detecting only the repetitive sequences and creating the intended library. Among the recombinant clones, the authors selected sequences of non-repetitious DNA derived from Y in order to study the organization ou*o of the human Y chromosome at the molecular level. This oo work, which is of decisive scientific interest, is again incapable of being used directly for determining the o .r sex of livestock embryos.
Several methods for early determination of the sex of human embryos have been proposed on the basis of the work by KUNKEL et al., i.e. using sequences of DNA 0 o specific for the Y chromosome. In particular, LAU et al.
(THE LANCET, 7 January 1984, p. 14-16) proposed a test S. 35 for determining the sex of the human embryo with the aid 3 -3of a probe isolated from the 3.4 kb human repetitive sequence derived from the heterochromatin of the Y chromosome (method of KUNKEL et This probe was then hybridized to DNA isolated from a small number of cells originating from 0.2 ml of amniotic fluid. The hybridization frequency is 1000 times greater for the male genomic DNA (isolated from cells of amniotic fluid) than for the female genomic DNA. The so-called "DOT BLOT" method proposed by GOSDEN et al. (THE LANCET, 10 March 1984, p. 540-541) uses a probe specific for the Y chromosome, which is called pHY2,1 and was described earlier by these authors. This probe hybridizes to DNA originating from a biopsy of chorionic villosities from a male human embryo.
LAMAR and PALMER (CELL, vol. 37, May 1984, p.
171-177) attempted to develop a general method for cloning the DNA of the Y chromosome in mice. The method proposed by these authors consists in fragmenting female mouse liver DNA by means of sonication and completely digesting male mouse DNA by MbOI. Samples of the o fragmented female DNA and the digested male DNA are mixed in a proportion of 100:1. The mixture is denatured and reassociated at a cot value of 1320 in an appropriate buffer: under these conditions, 95% of the DNA is in the form of double strands. These consist of homogeneous a0 female DNA, heterogeneous male-female double strands corresponding to the sequences common to both sexes, and finally male specific duplexes. The double strands Sare isolated by chromatography on a column of hydroxyapatite. They are recombined in the plasmid pBR322.
The recombinant plasmids are used to transform competent Escherichia coli HB101 bacteria. Approximately 100,000 r s clones (Amp -Tet s were tested, 3000 of which contained DNA presumed to be specific for the Y chromosome. Three Sof these probes proved to be specific for male mice,
A
PA..
w 4- 4 -4which would tend to demonstrate a species specificity of the molecular probes for male DNA.
Furthermore, several techniques have been proposed for sorting spermatozoa in order to determine their sex: so-called physical methods for separating the spermatozoa bearing the X and Y chromosomes respectively, by electrophoresis (Shishito and al., Int. J.
Fertil., 20, 13-16, 1975), gel filtration, passage through a gradient of albumin (Ericsson and al., Nature, vol. 246: 421-424, 1973), centrifugation, and more particularly centrifugation in a density gradient using Percoll (Fertility and Sterility, vol. 40, N° 5, Nov. 1983), ultracentrifugation in a density gradient of sucrose, etc.; methods for fractionating the sperm into fractions rich in spermatozoa bearing the Y chromosome and/or into fractions rich in spermatozoa bearing the X chromosome, by utilizing the difference in mobility 44,, between the spermatozoa bearing the Y chromosome and 20 those bearing the X chromosome, in various media (for S"o example gradients of albumin) (USP 4 009 260), as well o0 as spermatozoa separation methods capable of causing separa- So tion according to the density, by utilizing the fact that the density of the Y chromosome is lower than that of the X chromosome (USP 3 894 529), these methods comprising the application of hydrostatic forces (USP 4 092 229 and 44,' USP 4 155 831) and centrifugation in a gradient of an appropriate medium, for example Percoll it is also possible to separate into different fractions spermatozoa populations by reason of the sexlinked electrical charge resident thereon, aid of an electrostatic charge-bearing material (USP 4 083 957) falling into the same category as these methods of separation are the methods of cell sorting by flux cytometry, i.e. by deflecting and separating cells identified by their quantity of DNA, by means of an electric field, 5 followed by a Study of the sorted cells, for example by the attachment of other labeled ligands, optical or electron microscopy, functional tests in vitro, etc. (Application in Cell Biology, chap. 25;471-483, 1980) and immunological methods, some of which use antibodies which are selectively reactive with spermatozoa bearing either the X chromosome or the Y chromosome, the said antibodies being agglutinated and inactivated, thus releasing a fraction of spermatozoa homogeneously bearing the chromosome opposite in type to that which reacted with the above-mentioned antibody, it also being possible for the fraction fixed to the antibody to be released from the latter, if appropriate, especially in the case where the antibody is fixed to a solid phase made up of an immunoabsorbent material (USP 4 191 749, USP 3 687 806, USP 4 085 205).
The publications in which the pre-cited methods are also described are the following SHILLING E. In "Sex-ratio at birth prospects for Control." KIDDY and H.D. HAFS. Eds) Am. Soc. Animal. Sci.pp. 76-84 (1971) MEISTRICH M.L. J. Cell. Physiol., 80, 299-312 (1972) RHODE W. et al., J. Repro. Fertil. 42, 587-591 (1975) STEENO 0. et al., Andrologia, 7, 95-97 (1975) S- BHATTACHARYA B.C. et al., Ind. J. Exp. Biol., 14, 610-611 (1976) SHASTRY P.R. et al., Nature, 269, 58-60 (1977) SHILLING THORMAHLEN D. Zuchthyg, 11, 113-121 (1976) ADIMOELJA A. et al., Andrologia 9, 289-292 (1977) BHATTACHARYA B.C. et al., Int. J. Fertil., 22, 30-35 (1977) SCHILLING THORMAHLEN D. Andrologia, 9, 74-78 (1977) 6 PERTOFT H. et al., Anal. Biochem. 88, 271-282 (1978) SCHILLING E. et al., Andrologia 10, 215-217 (1978) QUINLIVAN Fertil. Steril., 34, 307-308 (1980) QUINLIVAN W.L.G. et al., Fertil. Steril, 37, 104-107 (1982) CORSON S.L. et al., Fertil. Steril, 40, 384-385 (1983) KANEKO S. et al., Fertil. Steril 40, 661-665 (1983) BEAL W.E. et al., J. Anim. Sci., 58, 1432-1436 (1984) KAKENO S. et al., Biomed. Res., 5, 187-194 (1984) UEDA K. et al., Dev. Growth Differ. 28, suppl.
Abst. 79 (1986) 0o ERICSSON R.J. et al. Nature, 246, 421-424 (1973) 0
S
0 ROSS A. et al. Nature, 253, 354-355 (1975) SHISHITO S.et al., Int. J. Fertil., 20, 13-16 (1975) 0 BROER K.H. et al., Andrologia, 9, 74-78 (1977) DMOWSKI W.P. et al., Fert. and Steril., 31, 52-57 (1979) QUINLIVAN W.L.G. et al., Fertil. Steril. 37, 0 104-107 (1982) on KNAACK J. et al., Tierzucht 27, 156-159 (1973) 00 o 0 LANG Chemtech. March, 189-192 (1973) SHIRAI M. et al., Tohoku. J. Exp. Med., 113 0 30 273-281 (1974) MOORE H.D.M. et al., Reprod. Fertil., 44, 329-332 (1975) a BATTACHARYA B.C. et al., Int. J. Fertil. 24, a 256-259 (1979) 35 HAMMERSTEDT R.H. et al., Arch. Biochem. Biophys.
194, 565-580 (1979) 0 y 4/ ~S) \^/jy 7 7- BENNETT D. and BOYSE E.A. Nature, 246, 308-309 (1973) BENNETT D. et al. Nature, 257, 237-238 (1975) SILVERS W.K. and WATCHEL Science, 195, 956-960 (1977) HANCOCK R. Biol. Reprod., 18, 510-515 (1978) SHALEV Diss Abst B, 40, 5538 (1980) HEDGE U.C. et al. J. Reprod. Immunol, 2, 351-357 (1981) WATCHET S.S. Theriogenology, 24, 419-429 (1984) GLEDHILL B.L. et al., In Flow Cytometry and Sorting Melamed, P. Mullaney and Mendelsohn, eds) John Wiley and Sons, Inc. N.Y. pp 471-484 (1979) MORUZZI J, Reprod.Fert, 57, 319-323 (1979) EVENSON D.P. et al., Science, 210, 1131-1133 (1980) o a EVENSON D.P. et al., Chromosoma, 78, 225-238 (1980) GROGAN W.M. et al., J. Histochem. Cytochem., 29, 733-746 (1981) STEEN H.B. et al., Cytometry, 2, 129 (1981) PINKEL D. et al., Science, 218, 904-905 (1982) PINKEL D et al., Cytometry, 3, 1-9 (1982) BENARON et al., Cytometry, 5 (1982) GARNER D.L. et al, Biol. Reprod., 28, 312-321 (1983) GLEDHILL B.L. et al., 10th Int. Congr. Anim.
f 4 Reprod.
PINKEL D. et al., J. Anim. Sci., 60, 1303-1307 (1985) JOHNSON et al., Gamete Res. in press (1986) JOHNSON L.A. and PINKEL Cytometry 7, in press (1986) r 8 JOHNSON Beltsville Symp. Agric. Res., X, (in press) M. Nijhoff publ. (1986) SHETTLES Int. J. Gynaecol. Obstet, 8, 643-647 (1970) DOWNING D.C. and BLACK D.L. Fertil. Steril., 27, 1191-1193 (1976) MUEHLEIS P.M. and LONG S.Y. Fertil. Steril., 27, 1438-1445 (1976) PORSTMANN T. and SCHMECHTA H. Dermatol. Monatsschr., 165, 28-35 (1979) BARLOW P. and VOSA Nature, 226, 961-962 (1970) BEATTY Cytogenet cell Genet., 18i, 33-49 (1977) ERICSSON R.J. et al., In Clinics in Andrology, vol. I, Emperaire, A. Audebert, E.S.E. Hafez, eds). Martinus Nijhoff, The Hague pp 98-111 Sa (1980) KIDDY C.A. and HAFS Sex ratio at birth.
Prospect and control. Am. Soc. Anim. Sci. publ.
(1971) COUROT Le choix du sexe est-il possible chez les mammiferes In "La F4condation" pp 113-130, Masson publ. (1975) RINEHART Sex Preselection not yet practical.
Population reports series I 2 pp 11 (1975) AMANN R.P. and SEIDEL Prospect for Sexing SMammalina Sperm, pp 288 Colorado Ass. Univ.
Press. publ. (1982).
The spermatozoa sorting methods proposed in the prior art share the disadvantage of having a relatively large margin of uncertainty as regards their reliability: in fact, the sorting processes do not give 100% homogeneous fractions of one or other chromosome, so that the sorting quality can only be checked in practice by -9carrying out artificial insemination, which is the ultimate aim (the efficiency of in vitro fertilization being rather low in practice). Moreover, in order to know whether the deviation of the "sex ratio" has a significant value in connection with a fraction of spermatozoa isolated by any one of the sorting methods recommended in the prior art, it is necessary to have carried out a large, statistically significant number of inseminations, which can prove expensive and timeconsuming.
It is therefore essential to have access to a means by which the fractions of spermatozoa obtained by any one of the sorting methods proposed according to the prior art can be checked immediately, so as to limit or even eliminate any risk of error at the stage of carrying out artificial insemination using the sorted fractions in question.
One object of the present invention was to provide molecular probes for DNA specific for the male genome of ruminants, especially of the subfamily of the bovines and particularly of the genus Bos, exhibiting sequences of DNA specific for the male sex, and a method for determining the sex of these animals with the aid of the above-mentioned probes, which satisfactorily meet the needs of the art in question insofar as they make it possible to determine the sex of said ruminant embryos from a small number o of embryonic cells not exceeding 500 to 1000, enabling the o sex of the embryos to be determined at an early stage of development with a reliability factor of 100 Another object of the present invention was to provide a method for immediately checking the proportion of spermatozoa bearing the Y chromosome in a fraction of a population of spermatozoa separated by any appropriate sorting method, using the molecular probe according to the present invention.
10 The present invention relates to a molecular probe for DNA specific for the male genome of ruminants especially of the subfamily of the bovines and particularly of the genus Bos, the said probe having a hybridization profile determined by hybridization of the said probe with male genomic DNA digested by an appropriate enzyme which reveals the presence of at least one band specific for the male genome of the ruminants in question, in particular when the hybridization profile determined by hybridization of the said probe with male genomic DNA digested by EcoRI reveals the presence of a band of the order of 7 kb which is specific for the male genome of the genus Bos.
In an advantageous embodiment of the molecular probe according to the present invention, said probe comprises 49 base pairs having the following nucleotide sequence 3'
ATCAGTGCAGGGACCGAGATGTGCTCCAAGGAGTGTTTATCGGCTGCTT
as well as its conpleentary, or a fragment of the said sequence containing at least 11 consecutive nucleotides or any other fragment presenting at least 70 homology with that latest, the said probe being designated by the name b.c.1.2.
According to another advantageous embodiment of the molecular probe according to the present invention, said probe is repeated at least 2000 times in the male o a genome of the genus Bos.
Its nucleotide sequence was determined by the method of MAXAM and GILBERT [METHODS ENZYMOL., 65, 499 (1977)].
Hybridization of the probe b.c.1.2. with male genomic DNA digested by EcoRI reveals the presence of a band of 7 kilobases (kb) which is absent in female genomic DNA.
The present invention also relates to processes for the preparation of a molecular probe for DNA specific
V
11 for the male genome of ruminants, especially of the subfamily of the bovines and particularly of the genus Bos.
According to one feature of the present invention, a process for the preparation of a molecular probe of this type, where genomic DNA segments which have been made single-stranded are reassociated from a mixture of male and female DNA in which the female DNA is in large excess (of the order of 100 parts per part of male DNA), comprises: a first step in which female genomic DNA of the said ruminants, is cut by means of sonication into fragments of 200 to 550 base pairs (bp) and then mixed, in a proportion of the order of 100:1, with male genomic DNA of same ruminants, digested by the endonuclease SAU 3A in order to release restriction fragments with sticky ends, having a size of between 40 and 1650 bp a second step in which the said mixture of DNA, after extraction, in a manner known per se, with a phenol/chloroform/isoamyl alcohol mixture and precipitation with ethanol, is denatured at 100°C and then reassociated at 68 0 C for 22 hours in a buffer containing 2 mol/l of (NH 4 2
SO
4 50 nrol/1 of sodium phosphate (pH 6.8) and 5 mr l/l of EDTA a third step in which the reassociated double-stranded DNA is mixed with a plasmid such as the plasmid pUC9 (Ampr-Lac which has first been unwound by the endonuclease BamHI and dephosphorylated with alkaline phosphatase, in the presence of the o ligase T 4 which effects the insertion of DNA into the ,1 plasmid, by contact for 16 hours at 16 0 C; and a fourth step in which the recombinant plasmids obtained in the previous step are used to transform Escherichia coli cells which have been made highly competent, th recombinant clones (Ampr-Lac being obtained in a proportion of about 200 clones for 2 ml of bacteria] cell suspension.
In one advantageous embodiment of the procesr tion of the molecular probe according to 4 12 the bacterial cells of Escherichia coli are made highly competent, prior to the insertion of the recombinant plasmids, by treatment for ten minutes at 0 0 C with a medium comprising 10 mmol/l of K-Mes (pH 100 mmol/l S of RbCl 2 45 mmol/l of MnC12 and 3 mmol/l of Co(NH 3 6 C1 3 In another advantageous embodiment of the process according to the present invention, the transformed bacteria are spread over a gelose medium containing ampicillin and X-gal (or 5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside) at a low concentration in dimethylformamide, the isolated bacterial colonies (Ampr-Lac Z are individually subcultured and then amplified with a view to preparing minilyzates, each isolated plasmid is then digested by the endonuclease PvuII, labeled with one or more radioisotopes and hybridized with genomic DNA originating from said ruminants, and the DNA of these animals is digested by the endonuclease EcoRI, which generates restriction fragments of variable size.
In an advantageous arrangement of this embodiment, these fragments are separated by electrophoretic migration on agarose gel.
According to another feature of the process for the preparation of a molecular probe for DNA specific for the male genome of ruminants especially for the subfamily of the bovines and particularly of the genus 0( 7-, 8 Bos, a probe of this type is obtained by synthesis; in the method of synthesis, the nucleotide sequence which the said probe comprises is synthesized by the phosphoramidite technique in solid phase.
In a preferred embodiment of the process for synthesizing the oligonucleotide which forms part of the composition of the molecular probe according to t'ie invention, the actual synthesis is followed by a purification step which consists in separating out the desired oligonucleotide of a given size, associated 4- IN 0- /i p I I 13 with oligonucleotides of intermediate size, by electrophoresis on a polyacrylamide gel, and then identifying the band of the desired pure oligonucleotide with the aid of an aluminum foil coated with silica gel, which is fluorescent at 254 nm, cutting out this band and eluting the DNA in an appropriate solution, and then recovering the pure DNA synthesized.
In another preferred tmbodiment of the process for synthesizing the molecular probe according to the invention, the latter is labeled with one or more radioisotopes, after purification of the synthesized oligonucleotide.
The present invention also relates to the use of the molecular probes for DNA specific for the male genome of ruminants, especially of the subfamily of the bovines and particularly of the genus Bos, for determining the sex of embryos oo "and fetuses of the said ruminants, in which determination process a probe according to the invention, hybridized to a filter prehybridized in an appropriate manner known per se, when S 20 the said probe is reassociated with genonic DNA of said ruminants male and female transferred 0 beforehand onto an appropriate filter after having been isolated by electrophoresis on agarose gel, hybridizes exclusively to the male genomic DNA and this hybridization is demonstrated by autoradiography and/or by means oe of a non-radioactive probe, by the presence of hybridization signals in the form of bands [SOUTHERN, J. Mol. Biol., 98, 503 (1975)].
In an advantageous embodiment of the sex determination method according to the invention, the DNA to be recognized is contained in lymphocytes of the above-mentioned ruminants.
In another advantageous embodiment of the sex determination method according to the invention applied to fetuses, the DNA to be recognized is contained in cells issued from ammniotic or allantoldic fluid or from chorionic villosities 14 of the above-mentioned ruminants.
According to the invention, said cells or similar of the above-mentioned ruminants are deposited on a membrane (dot-blot) in the form of drops after having been sonicated.
In yet another advantageous embodiment of the sex determination method according to the invention, the DNA to be recognized is contained in the Y chromosome of the said ruminants, observed at the metaphase stage, in which case the sex is determined by so-called in situ hybridization.
In a further embodiment of the sex determination method according to the invention, the DNA to be recognized is contained in nuclei of cells of the said ruminants at the interphase stage, in which case the sex is determined by socalled in situ hybridization, In the in situ hybridization according to the invention, a biopsy of 5 to 20 cells from an embryo of said ruminants is brought into contact with the molecular probe according to othe invention for effecting the labeling of said cells by hybridization with said probe labeled with one or more radioisotopes or with a non-radioactive probe,then the hybridization is revealed by an appropriated cytoimmunochemical method.
The present invention also relates to a process for directly and immediately checking the proportion of spermatozoa bearing the Y chromosome in a population of spermatozoa 25 of ruminants, especially of the sub-family of the bovines and more particularly the genus Bos, wherein the spermatozoa of the said population are brought into contact with the molecular .i probe according to the invention in order to label the said spermatozoa by hybridization with the said probe suitably labeled, and the hybridized spermatozoa are then revealed, by an appropriated cytoimmunochemical method.
In one advantageous embodiment of the checking process according to the present invention, the hybridization of the spermatozoa with the molecular probe for specific DNA is effected in situ directly with the spermatozoa.
15 In another advantageous embodiment of the checking process according to the present invention, the hybridization is effected between the molecular probe for specific DNA and the DNA isolated from spermatozoa of ruminants of the genus Bos.
In an advantageous arrangement of the embodiment in which the hybridization is effected in situ, the spermatozoa are subjected, prior to the hybridization step, to a chemical decondensation process comprising essentially three steps, namely: hypotonic shock, proteolytic digestion and reduction of the disulfide bridges.
In yet another advantageous embodiment of the checking process according to the present invention, a probe labeled with one or more radioisotopes, or a non-radioactive probe, is used as the molecular probe for specific DNA.
The process for checking the proportion of spermatozoa bearing the Y chromosome in a population of spermatozoa, according to the present invention, makes it possible to measure the proportion of Y chromosomes present in this population.
According to the present invention, this possibility of determining the quantity of Y-specific S 25 DNA in spermatozoa, by means of the probe for specific DNA according to the invention, is utilized to develop a process for sorting the X and Y spermatozoa according to their DNA content, the various separation steps of this process being themselves checked by means 3 of the molecular probe specific for the ruminant Y chromosome according to the invention.
As a consequence, the present invention also relates to a process for sorting the spermatozoa bearing the X chromosome and the spermatozoa bearing the Y chromosome in a population of spermatozoa, which com- Ir 16 prises the following steps: 1) labeling the DNA contained in the spermatozoa with a vital stain specific for DNA (for example ethidium bromide, acridine, Hoechst stain 33342 or DAPI); 2) sorting, by cytofluorometry, into two fractions of X and Y spermatozoa according to the quantity of DNA which they contain; 3) checking the quality of the sorting operation carried out in the 2nd step of the process by using the process for checking the proportion of spermatozoa bearing the Y chromosome in the fraction of Y spermatozoa separated out by sorting, according to the present invention; 4) immunizing rodents (mice or rats) with the checked fractions, which may have been re-sorted following the check, with a view to producing monoclonal or polyclonal antibodies; 5) checking the specificity of the said antibodies, by means of agglutination, spermatotoxicity, indirect immunofluorescence and flux cytometry tests, in order to obtain specific immunological reagents recognizing 2 antigenic determinants controlled by the chromosome of the desired sex and expressed at the surface of the spermatozoa, which reagents are capable of being used to separate live spermatozoa bearing the X chromosome or the Y chromosome; 6) and separating the fractions of spermatozoa respectively bearing the X chromosome o a 25 and the Y chromosome in a population of spermatozoa, with the aid of the said immunological reagents.
In one advantageous embodiment of the sorting ,process according to the present invention, the immuniza- Stion of rodent mammals, which constitutes the 4th.steos of the sorting process, is followed by collection of the polyclonal antibodies resulting from the said immunization and by absorption of these antibodies on spermatozoa of the opposite sex to that used for immunization, the specificity of these antibodies being checked on spermatozoa of the desired sex, and the said antibodies :~cl 1 i_ 'i 17then being purified if appropriate.
In another advantageous embodiment of the sorting process according to the present invention, the X and Y spermatozoa separated by cytofluorometry are used to prepare monoclonal antibodies specific for the X and Y chromosomes.
The present invention further relates to the specific immunological reagents recognizing antigenic determinants controlled by the X or Y chromosome used to obtain the said reagents, and expressed at the surface of the spermatozoa, the said reagents consisting of the antibodies obtained by carrying out the above process, tested for their specificity and purified if appropriate.
In addition to the .foregoing provisions, the invention also includes other provisions which will become apparent from the following description.
The invention will be understood more clearly with the aid of the following additional description, which refers to examples of how the present invention o, 20 can be put into practice.
It must be clearly understood, however, that these examples are given solely in order to illustrate the object of the invention without in any way implying a limitation.
0 4o 400 4,Q 44 4r EXAMPLE 1 PREPARATION OF PROBES ACCORDING TO THE INVENTION The technique used enables the DNA present in the male genome and absent in the female genome to be cloned and has thus made it possible to build a library of DNA specific for the male bovine.
BUILDING THE LIBRARY OF DNA SPECIFIC FOR THE MALE 1 mg of female genomic DNA originating from peripheral lymphocytes is cut by means of sonication 1 into fragments of 200 to 550 base pairs 10 Pg of o ANC Yv) r 18 male genomic DNA originating from peripheral lymphocytes are digested by the endonuclease SAU 3A (Boehringer), thus releasing restriction fragments with sticky ends, having a size of between about 40 and 1650 bp.
These two types of fragment are mixed in the following proportion: female DNA male DNA 100 1, After extraction with a phenol/chloroform/ isoamyl alcohol mixture and precipitation with absolute ethanol, the mixture of the two DNA's is denatured at 100 0 C for 10 min. and then reassociated at 68 0 C for 22 hours in a buffer containing 2 mol/l of (NH 4 2 S0 4 mmol/l of sodium phosphate (pH 6.8) and 5 mmol/l of EDTA. An aliquot (1 pg) of reassociated doublestranded DNA is mixed with 100 ng of the plasmid pUC9 (Ampr-Lac which has first been unwound by the endonuclease BamH1 (Boehringer) and dephosphorylated with O alkaline phosphatase (CIP Boehringer). The insertion of the male bovine DNA into the plasmid is effected °o with the ligase T 4 (Biolabs) at 16 0 C for 16 hours.
o 20 The recombinant plasmids are used to transform 2 ml of Escherichia coli-JM83 bacteria which have been made highly competent by treatment with a medium containing 10 mmol/l of K-Mes (pH 100 mmol/l of RbC1 2 45 mmol/l of MnCl 2 and 3 mmol/l of Co(NH 3 6 C13' oo 8 25 for 10 min. at O0C. The bacteria transformed in this way are spread over LB-Agar medium containing 100 pg/ml of ampicillin and 2 Pl/ml of X-gal (5-bromo-4-chloro-3indolyl-p-D-galactopyranoside) at a concentration of 2% in dimethylformamide. Approximately 200 clones (Ampr-Lac Z) were obtained.
EXAMPLE 2 ANALYSIS OF THE LIBRARY To investigate the presence of male bovine DNA S inserts, each clone is individually subcultured and the 19 plasmids are isolated from the bacteria by means of minilyzate. Each isolated plasmid is digested by the endonuclease PvuII(Boehringer) and analyzed by electrophoresis in 1% agarose gel (30 volts 16 h).
Fifty of the 200 clones analyzed contain bovine DNA (insert).
The specificity of the inserts produced in this way was demonstrated by hybridization with male and female genomic DNA (lymphocytes) digested by the endonuclease EcoRI (Boehringer) and transferred, after electrophoresis, onto DBM paper or HYBOND membranes (AMERSHAM) by SOUTHERN's technique.
Hybridization of the probe b.c.1.2. with male genomic DNA digested by EcoRI reveals the presence of a band of 7.0 kilobases (kb) which is absent in the o female genomic DNA. This result was confirmed by studying 12 male and 13 female animals (p<10 SEXAMPLE 3 PREPARATION OF THE BOVINE GENOMIC DNA o The male and female bovine DNA is purified from x 10 7 peripheral lymphocytes. The cells are incubated at 42°C for 18 hours, with slow stirring, in 10 ml of lysis solution [10 mmol/l of Tris-HCl pH 7.5, 10 mmol/l 5 25 of ethylenediaminetetraacetate-Na 2 (EDTA), 50 mmol/l of oo" NaCI, 0.4% of sodium dodecyl-sulfate plus 2 mg of proteinase K (Boehringer)]. 1 mg of ribonuclease A 4, 4 (Boehringer) in 1 ml of 10 mM Tris-HCl pH 7.5, containing 1 mmol/l of EDTA, is added in 1 hour at 37 0 C, this being followed by a second digestion by proteinase K (1 mg, 1 h at 42 0 The lyzates are extracted 3 times with ml of a mixture made up of phenol, chloroform and isoamyl alcohol (3:1:0.01 saturated with 0.2 mol/l of Tris-HCl pH 7.5. The aqueous phases are washed 3 times with a chloroform/isoamyl alcohol solution (1:0.04).
.PAI
c -1 I 20 The DNA is precipitated with 2 volumes of absolute ethanol in the presence of 150 mmol/l of NaC1, and washed with an 80% solution of ethanol in water.
DIGESTION BY THE RESTRICTION ENDONUCLEASES 15 Fg samples of bovine DNA are digested at 37°C for 18 hours by the restriction endonuclease EcoRI (Boehringer) in an incubation buffer containing 100 mmol/l of Tris-HCl, 50 mmol/l of NaCI and 10 mmol/l of MgCl 2 pH 7.5. Complete digestion is obtained with a total of 6-10 units per pg of DNA, added in 3 portions. The digested DNA fragments are subjected to electrophoretic separation in 0.7% agarose gel in a buffer containing 0.04 mol/l of Tris-CH 3 COOH pH 8 and 0.002 mol/l of EDTA. The gel is calibrated by including a sample of phage-Lambda DNA digested by HindIII.
TRANSFER
The DNA fragments contained in the gel are To a depurinated for 15 min. at room temperature in 0.25 M HC1, denatured in 0.5 M NaOH 1.5 M NaCl and then 20 neutralized by being passed successively through 1.5 M phosphate buffer pH 5.5 (3 x 15 min.) and then 0.15 M pH 5.5 (2 x 15 min.). A "Nylon" membrane (Hybond-N Amersham or Pall-Biodyne-A Flobio) is then placed on the gel and the DNA fragments contained in the gel are 25 transferred onto the membrane by capillarity. After 0 O 4 transfer for 16 hours in 20 x SSC, the membrane is washed in 2 x SSC, dried in air and then placed in an oven at for 2 hours.
LABELING THE PROBE WITH 32P 100 to 200 ng of the probe in a volume of 1 to 5 Pl, are added to the following reaction mixture: 50 pmol of dATP (1 pl), 50 pmol of dTTP (1 pl), 32-dGTP (5 p) and pmol of dCTP (1 pl), 50 pCi of o-2P-dGTP (5 pl) and 2 P 1 of a reaction buffer containing 500 mmol/l of Tris-HCl pH 7.5, 500 mmol/1 of HgCl and 100 mmol/l of i- 21 P-mercaptoethanol. The reaction is performed at 16 0
C
for 1 hour 30 min. and then stopped by the addition of 200 P 1 of a solution containing 10 mmol/l of Tris-HCl pH 7.5, 80 mmol/l of EDTA and 0.5% of sodium dodecylsulfate.
The radiolabeled probe is separated from the nucleotides by passage through a column (10 cm x 1 cm) of Sephadex G100 (Pharmacia) and eluted with a buffer containing 10 mmol/l of Tris-HCl pH 7.5 and 1 mmol/l of EDTA. The fractions of eluate containing the most radioactivity are then pooled.
PREHYBRIDIZATION AND HYBRIDIZATION The filters (blots) are prehybridized at 42 0
C
for 4-10 hours with a mixture containing 50% v/v of deionized formamide, 1 mol/l of NaCl, 0.2% of Denhart's solution, 2.5% of dextran sulfate, 0.1% of sodium dodecyl-sulfate and 0.5 mg/ml of sonicated salmon sperm
DNA.
Hybridization is effected in the same mixture, except that the dextran sulfate is at 5% and the NaC1 at 0.5 mol/l. The 3 2 P-radiolabeled probe, denatured at 100 0 C for 10 min., is added to the hybridization mixture at a rate of 1 x 10 cpm/ml, which represents about ng of probe per ml. Hybridization is effected at 42 0 C for at least 18 hours. After hybridization, the filters are washed firstly at 65 0 C for 30 min. in a buffer containing 2 x SSC (0.3 mol/1 of NaCl and 0.03 mol/l of sodium citrate) 0.1% of SDS and then for a Sfurther 30 min. in the same buffer diluted (0.2 x SSC). The filters are then placed in a cassette equipped with "Cronex" intensifiers (DUPONT), which is brought into contact with a KODAK XAR-5 film for autoradiography at -70°C for 6 to 24 hours.
DEHYBRIDIZATION
This is effected by washing the filters at 37°C 22 for 30 min. with 0.4 M NaOH and then in a solution containing:O.2 mol/l of Tris-HCl pH 7.5, 0.1% of sodium dodecyl-sulfate and 0.1 x SSC.
PREPARATION OF THE DOT-BLOTS 1) Genomic DNA dot-blot The genomic DNA of male and female bovines was sonicated for 5 min. (Branson Sonifier B-15) and then diluted with sonicated salmon sperm DNA in proportions such that the total quantity of DNA deposited was 2 pg.
The concentration range of bovine DNA was 1 pg, 0.5 ug, 0.25 pg, 0.1 pg and 0.05 pg for a 1 pl deposit.
After deposition of the DNA on Pall-Biodyne A membranes, the latter are treated with 0.5 N NaOH N NaCl for 5 min. and then neutralized with 1.5 M phosphate buffer pH 5.5 for 2 x 5 min. and 0.3 M phosphate buffer pH 5.5 for a further 5 min. The membranes are 0 0 I nooo subsequently dried on a Whatman 3MM and the DNA is then Sfixed at 80 0 C for 2 hours. The ready-to-use filters are stored in the prehybridization solution at 4°C.
2) Dot-blot of the bovine cells The peripheral lymphocytes of the male and female bovine were sonicated for 6 minutes and then treated with proteinase K (Boehringer) for 1 Shour at 42°C, the dilution range corresponding to 1 x 5 6 5 5 4 4 03 S 25 10 6 5 x 10 1 x 10 5 x 10 1 x 10 and 5 x 10 o' cells in 2 pl. The sonicated salmon sperm DNA is added to make the total DNA up to 2 pg.
After deposition of the DNA on a Pall-Biodyne A membrane, the treatment is identical to that of the genomic DNA dot-blot.
Hybridization of the dot-blots and visualization of the signals are the same as for blots in general.
1 23 EXAMPLE 4 SYNTHESIS OF THE OLIGONUCLEOTIDE AND PURIFICATION OF THE SYNTHESIZED OLIGONUCLEOTIDE The chemical synthesis of the oligonucleotide corresponding to the predetermined sequence was carried out with the aid of an "Applied Biosystems" automatic synthesizer by the phosphoramidite technique in the solid phase.
As the reaction is 95-97% efficient at each stage, it is necessary to purify the final product (the probe b.c.1.2. 49 mer) to remove the intermediate oligonucleotides. About 7 mg of the mixture of oligonucleotides in 60 Pl of H20 are separated by electrophoresis in a gel containing 20% of polyacrylamide 8 mol/l of urea, at 700 V, 38 mA, for 3 hours. The a band corresponding to the 49 mer is identified with the aid of an aluminum foil coated with silica gel, which is fluorescent at 254 nm (Merck). This part of the gel is cut out and the DNA is then eluted in 1.5 ml of a solution containing 0.5 mol/l of CH 3
COONH
4 mmol/l of EDTA, at 37°C for 16 hours, with stirring.
The supernatant is concentrated to about 300 pl and the urea is removed by chromatography on a 10 cm x 1 cm column of Sephadex G-50 (Pharmacia) equilibrated with a buffer containing 10 mmol/l of Tris-HCl pH 7.5 1 mmol/l of EDTA. The DNA isolated in this way is lyophilized and stored at -20 0
C.
RADIOACTIVE LABELING P) OF THE SYNTHESIZED PROBE b.c.1.2. (single-stranded) 10 to 20 pmol of the probe in a volume of 3 l, are added to 23 pl of a reaction mixture made up of 100 mmol/1 of dithiothreitol (2.5 pl), 10 mmol/l of spermidine (2.5 pl), an incubation buffer containing 500 mmol/l of Tris-HCl pH 7.5 100 mmol/ of MgCl 5 r^ (2.5 100 pCi (y-32) of adenosine triphospha (2.5 pl) 1 of adenosine triphosphate r -r U .i -L 1 ac eo su o 24 ATP 3000 Ci/mmol (Amersham) and 20 U of T4 polynucleotide kinase (Boehringer). After incubation for min. at 37 0 C, the reaction is stopped with 2 P 1 of 400 mM EDTA and the labeled oligonucleotide is separated from the ATP by column chromatography with Sephadex G- EXAMPLE
SEQUENCING
PREPARATION OF THE PLASMID b.c.1.2. FOR THE SEQUENCING OF ITS 2 STRANDS a) Lower strand (direction Thirty micrograms of the plasmid b.c.1.2. are digested by the endonuclease HindIII for 3 hours at 37°C. The enzyme is removed by extraction with a phenol/chloroform/isoamyl alcohol mixture (3:1:0.01 The DNA is subsequently precipitated in 1 volume of isopropanQl in the presence of 0.3 mol/l of CH 3 COONa and then washed in an 80% solution of ethanol in water.
The DNA of the unwound plasmid is labeled in the 3'-position, via the terminal enzyme transferase, with 32 P-dideoxyadenosine triphosphate (SA 3000 Ci/ mmol) by the technique of kit no. N 4020 from AMERSHAM.
DNA of the plasmid 40 P 1 25 ddATP (125 pCi) 13 pl Amersham buffer x 10 10 pl Distilled water 95 p 1 AMERSHAM enzyme solution 5 P 1 Incubation: 1 hour at 37 0
C.
The labeled plasmid is subsequently separated from the nucleotide by passage over Sophadex G75 and then digested by the endonuclease EcoRI, which generates 2 fragments having respective sizes of 2.6 and 0.1 kb.
The 0.1 kb fragment, containing the insert b.c.1.2., is isolated by electrophoresis in 2% agarose gel. It 0 0 0 0
T
s t C ~ar~M---earrrr*Unr^ 25 is then purified by passage over glass wool and extraction with a phenol/chloroform/isoamyl alcohol mixture.
The purified fragment is sequenced by MAXAM and GILBERT's method modified by the company N.E.N.
The fragments to be sequenced are analyzed by electrophoresis in 0.2 mm of a gel containing 8% and 12% of polyacrylamide, on a Macrophore LKB cell [GAROFF and ANSORGE, Analytical Biochemistry, 115 (450-457) 1980]. Depending on the concentrations, the migration times were 6 h-7 h and 2 h.
The gels are then fixed with 10% acetic acid for 10 min., washed with water and then dried at room temperature.
4 0 26 Autoradiography of the gel is effected on a URNO HS 90 film for exposure times of 24, 48 and 72 hours.
b) Upper strand (direction The techniques are the same, except that the first digestion enzyme is EcoRI and the second is PVU
II.
Determination of the nucleotide sequence of the probe obtained from peripheral lymphocytes of mammals of the genus Bos, which is composed of the following 49 base pairs: 3'
ATCAGTGCAGGGACCGAGATGTGCTCCAAGGAGTGTTTATCGGCTGCTT
made it possible to synthesize the probe according to the invention, as described in Example 4 above.
The probe b.c.1.2. according to the invention 0o oo has a high sensitivity since tests carried out on PALL BIODYNE membranes showed that a quantity of 50 ng of bovine DNA is sufficient to give a positive signal.
EXAMPLE 6 DETERMINATION OF THE DNA BAND SPECIFIC FOR THE Y CHROMOSOME IN A GIVEN POPULATION OF SPERMATOZOA A. Preparation of DNA from bovine sperm Each straw, containing about 15 to 20 x 106 25 frozen spermatozoa, is immediately immersed in a water bath at 37 0 C for about 30 seconds. The contents of each straw are then diluted in 1 to 2 ml of sterile PBS.
Each tube is centrifuged at 500 g for 10 min. The supernatant is removed and the residue is taken up in 1 to 2 ml of sterile PBS. This washing process is repeated 4 times. After the last centrifugation, the 0 residue of spermatozoa is resuspended in 10 ml of a lysis buffer containing 0.01 mol/l of Tris-HCl pH 0.1 mol/1 of NaCl, 0.01 mol/l of EDTA, 1% of SDS and 2% 27 of (-mercaptoethanol. This buffer is preheated to 50 0
C.
After incubation for 30 minutes at 50 0 C, 2 mg of proteinase K (final concentration: 200 pg/ml) are added to each tube and incubation is continued for 2 hours at 50 0 C, with slow stirring.
The mixture is then extracted for 15 minutes at room temperature with 15 ml of a solution consisting of 50% of phenol saturated with 0.2 mol/l of Tris pH and 50% of chloroform/isoamyl alcohol (24:1).
The lower organic phase is removed and extraction is repeated a further twice.
The aqueous phase is then extracted 2 to 3 times for 15 minutes at room temperature with a chloroform/isoamyl alcohol mixture After the last extraction, the aqueous phase is centrifuged at 2000 g for 30 minutes to remove all the chloroform and O the precipitated proteins. The clarified supernatant o is then mixed with 21 volumes of absolute ethanol which 0 has been cooled beforehand at -20°C for 15 minutes.
S 20 When the DNA has precipitated, it is recovered with a sterile pipette and washed for 5 min. in 70% ethanol.
o o The excess alcohol is evaporated off and the DNA is dissolved in a sterile buffer containing 0.001 mol/l of Tris-HCl pH 8.0 and 0.0001 mol/1 of EDTA.
B. Digestion by the restriction endonucleases Oo,0* 15 pg samples of bovine spermatozoa DNA are digested at 37 0 C for 18 hours by the restriction K endonuclease EcoRI (Boehringer) in an incubation buffer containing 100 mmol/1 of Tris-HCl, 50 mmol/l of NaCl and 10 mmol/l of MgC12, pH 7.5. Complete digestion is obtained with a total of 6-10 units per pg of DNA,added S* in 3 portions. The digested DNA fragments are subjected to electrophoretic separation in 0.7% agarose gel in a buffer containing 0.04 mol/1 of Tris-CH 3
COOH
pH 8 and 0.002 mol/1 of EDTA. The gel is calibrated by -28 including a sample of phage-Lambda DNA digested by Hind
III.
Transfer The DNA fragments contained in the gel are depurinated for 15 min. at room temperature in 0.25 M HC1, denatured in 0.5 M NaOH 1.5 M NaCl and then neutralized by being passed successively through 1.5 M phosphate buffer pH 5.5 (3 x 15 min.) and then 0.15 M pH 5.5 (2 x 15 min.). A "Nylon" membrane (Hybond-N Amersham or Pall-Biodyne-A Flobio) is then placed on the gel and the DNA fragments contained in the gel are transferred onto the membrane by capillarity. After transfer for 16 hours in 20 x SSC, the membrane is washed in 2 x SSC, dried in air and then placed in an oven at 80°C for 2 hours.
Labeling the probe with 32 100 to 200 ng of the probe in a volume of 1 to 5 il, are added to the following reaction mixture: 50 umol of dATP (1 50 Pmol of dTTP (1 Pl), 50 pmol 20 of dCTP (1 pl), 50 PCi of C- P-dGTP (5 pl) and 2 pl of Sa reaction buffer containing 500 mmol/l of Tris-HCl pH %oo 7.5, 500 mmol/l of MgCl 2 and 100 mmol/l of P-mercaptoethanol. The reaction is performed at 16°C for 1 hour minutes and then stopped by the addition of 200 pl of a solution containing 10 mmol/l of Tris-HCl pH B u* 80 mmol/l of EDTA and 0.5% of sodium dodecyl-sulfate.
The radiolabeled probe is separated from the Snucleotides by passage through a column (10 cm x 1 cm) of Sephadex G100 (Pharmacia) and eluted with a buffer containing 10 mmol/l of Tris-HCl pH 7.5 and 1 mmol/l of EDTA. The fractions of eluate containing the most radioactivity are then pooled.
SC. Prehybridization and hybridization The filters (blots) are prehybridized at 42 0
C
Sfor 4-10 hours with a mixture containing 50% v/v of "0A T
I
29 deionized formamide, 1 mol/l of NaCI, 0.2% of Denhart's solution, 2.5% of dextran sulfate, 0.1% of sodium dodecyl-sulfate and 0.5 mg/ml of sonicated salmon sperm
DNA.
Hybridization is effected in the same mixture, except that the dextran sulfate is at 5% and the NaCI at 32 mol/l. The 3P-radiolabeled probe, denatured at 100°C for 10 min., is added to the hybridization mixture at a rate of 1 x 10 6 cpm/ml, which represents about 10 ng of probe per ml. Hybridization is effected at 42 0 C for at least 18 hours. After hybridization, the filters are washed firstly at 65 0 C for 30 min. in a buffer containing 2 x SSC (0.3 mol/l of NaCl and 0.03 mol/l of sodium citrate) 0.1% of SDS and then for a further 30 min. in the same buffer diluted (0.2 x SSC). The filters are then placed in a cassette p. equipped with "Cronex" intensifiers (DUPONT), which is oOd brought into contact with a KODAK XAR-5 film for autoradiography at -70 0 C for 6 to 24 hours.
20 D. Results °0 2 The bovine spermatozoa DNA digested by the gos orestriction enzyme EcoRI and then hybridized with the radiolabeled probe b.c.1.2. has an analogous hybridization profile to that obtained with the other bovine cell 25 types tested by the inventors.
EXAMPLE 7 S' DETERMINING OF THE SEX OF BOVINE EMBRYOS BY IN SITU HYBRI- DIZATION WITH AN ADN BIOTIN-LABELED PROBE (NON-RADIOACTIVE S PROBE).
A. Preparation of the cells The cells used come from bovine embryos of 7-8 days old. After been dissected, the cells are deposited on a 1 slide and incubated for 10 to 15 minutes in a fixative solution, such as a mixture of alcohol/acetic acid (3:1 v/v) X 5 then dried in air. The slides are used immediately or, 30 in case of a later sex determining, kept at -4 0 C and sheltered from dust.
B. Labeling the probe with biotin A fragment of the plasmid pUC9 containing the insert b.c.1 is used, the whole fragment amounting to 350 bp. The 350 bp fragment is obtained by digestion by the restriction enzyme PVUII, purified by electrophoresis on agarose gel and extracted from the gel by absorption onto a DEAE NA45 membrane (Schleicher and Schuell) The probe is labeled with biotin by nick translation using the following constituents in a final volume of 0.050 ml: dATP, dGTP and dCTP 0.2 mmol of each BRL DNA Polymerase I 0.4 unit/pl DNase I 40 pg/pl DNA to be labeled 1 pg Biotin-labeled dUTP 0.4 mmol Incubation is carried out for 90 minutes at 0 20 15 0 C and the reaction is stopped with 300 mmol/l of 'o Na EDTA 5% of SDS (BRL protocol).
After labeling, the probe is purified by gel o0 filtration on a column of Sephadex G-100. The various o fractions collected are analyzed separately with the aid of the system streptavidine-alkaline phosphatase (DNA Detection System BRL ref. B239 SA).
The positive fractions are mixed and the activity of the pool is measured by comparison with a known quantity of biotin-labeled DNA.
C. Technique of hybridization on slides The slides are incubated with 90 to 100 pl of hybridization liquid and covered with a plastic film (to prevent evaporation).
After denaturation for 10 min. in an oven at 100 0 C, the slides are placed in a moist chamber and A incubated at 42 0 C for 16 hours.
31 The final composition of the hybridization liquid is as follows: 4 x SSC 1 mmol/1 of EDTA 25 mmol/l of Tris-HCl pH 7.3 i 1 x Denhardt of dextran of deionized formamide Probe: 80 ng/ml of hybridization medium (1 x SSC 0.15 M NaCI, 0.015 M Na citrate) (1 x Denhardt 0.02% of BSA or 0.02% of skimmed milk powder, 0.02% of polyvinylpyrrolidone and 0.02% of Ficoll) After removal of the plastic film, the slides are washed successively in the following solutions: 2 x SSC (30 minutes at room temperature), then 0.1 x SSC (30 minutes at 42 0 2 x SSC (15 minutes at room .a ao temperature) and finally PBS pH 7.4, to which 0.1% v/v 0 'of Triton x 100 and 0.5% of skimmed milk powder 20 (Regilait) have been added.
o 0 D. Developing S The slides, which are still moist after the I 0 "o excess fluid has been removed, are then incubated for 1 hour at 37°C with an antibiotin goat antibody or an antibiotin rabbit antibody. This antibody is sold in a form purified by affinity chromatography (Vector *ol£ Laboratories ref. SP-3000) and is used in our tests as a 1:350 dilution in PBS pH 7.4 0.1% of Triton
'S
x 100 0.5% of skimmed milk powder.
After washing for 15 minutes at room temperature in PBS pH 7.4 0.1% of Triton x 100 0.5% (w/v) of skimmed milk powder, the slides are incubated for 1 hour at 37 0 C with a conventional anti-goat rabbit antibody or a conventional anti-rabbit goat antibody LxAN 4T ^T~Iy 32 coupled to peroxidase (Biosys ref. BI 2403) as a 1 dilution in PBS pH 7.4 0.1% of Triton 0.5% of skimmed milk powder.
The slides are then washed for two times minutes in PBS pH 7.4, which this time contains 0.1% of Tween 20, and finally for 5 minutes in PBS pH 7.4.
They are incubated for 5 to 8 minutes at room temperature with a solution of diaminobenzidine (DAB SIGMA ref. D 8001 containing 0.5 mg/ml in PBS pH 7.4 containing 0.01% of H2 02 The amount of precipitate formed by the reaction of the peroxidase with the DAB is increased by the successive precipitation of gold and silver salts in accordance with the process described by BURNS et al.
(Journal Clinical Pathology, 1985, 35, 1085-1092): In a first stage, 50 to 100 pl of a 2.5 mM solution of Na chloroaurate (NaAuCl BDH ref. 30125 2R) 4 are deposited on each slide and the slides are incubated for 5 min. at room temperature. After washing for min. in distilled water, the slides are incubated for 09 5 min. at room temperature with 50 to 100 P 1 of a 0.1 M 0 n solution of Na sulfide (Na 2 S, SIGMA ref. S 2006), rinsed for 5 min. with distilled water and incubated for 4 to 8 minutes with 100 to 300 pl of silver reagent.
The composition of the silver reagent is as follows: A Na carbonate 0.24 mol/l (SIGMA ref. S 4132) B1 Ammonium nitrate 13 mmol/l (SIGMA ref. A 9642) B2 Silver nitrate 6 mmol/l (BDH ref. 303873N) B3 Dodecatungstosilicic acid 1.5 mmol/1 (BDH ref. 305453R) B4 37% formaldehyde 0.6 l/i/ml (SIGMA ref. F 1635) The silver reagent is prepared by successively solutions B1, B2, B3 and B4, with stirring. The
I
33 mixture obtained is added in a proportion of 1:1 to solution A and the reagent prepared in this way is used immediately.
After treatment with the silver reagent, the slides are washed with distilled H O for 15 minutes and then in 1 acetic acid for 2 times 15 minutes and finally stained for 1 minute with a 1 solution of Pyronin Y (SIGMA ref. P 7017) in H 2 0, rinsed for a few seconds in distilled water, dried in hot air and mounted in DPX.
E. Results of the spermatozoa After in situ hybridization, the presence of a specific label can be detected on the spermatozoa. The background is negligible. An increase in the volume of the head of the spermatozoa is evidence of their decondensation.
After in situ hybridization, the presence of the labeling is observed with an optical microscope. The specific labeling is detectable on about 80 to 100 of the male cells and is totally absent with the female cells.
a 0 0 20 The labeling appears as a brown-black precipate at nuclei of male cells level.
EXAMPLE 8 "CHECKING THE QUALITY OF THE SORTING OF A POPULATION OF SPERMATOZOA BY IN SITU HYBRIDIZATION ON SPERMATOZOA WITH A BIOTIN-LABELED DNA PROBE WITH A DNA PROBE SPECIFIC TO THE GENUS OF THE MALE SEX tA. Preparation of the cells The cells used are bull spermatozoa frozen and stored in liquid nitrogen. One straw, i.e. about 30 13,000,000 live spermatozoa, is defrozen. The straws are reheated for 30 seconds at 37 0 °C and the sperm is then diluted in 1 ml of sterile PBS.
A series of centrifugations are carried out in order to remove the maximum amount of freezing medium.
The suspension of spermatozoa in PBS is first centri- I iii i -LI P- 34 fuged for 10 min. at 500 g, the supernatant is sucked off and the spermatozoa are taken up in 1 ml of 0.11 M sodium citrate. The mixture is centrifuged for 10 min.
at 500 g. The supernatant is sucked off, the residue is taken up in 1 ml of 0.11 M sodium citrate 5 of DMSO and the mixture is centrifuged for 10 min. at 500 g. The supernatant is sucked off and the residue is resuspended in 1 ml of 0.11 M sodium citrate 15 of DMSO. The mixture is centrifuged for 10 min. at 500 g. The supernatant is sucked off and the residue is resuspended in 1 ml of 0.11 M sodium citrate 50 of DMSO. The mixture is centrifuged for 10 min. at 500 g. The supernatant is sucked off and the residue is resuspended in 1 ml of 0.11 M sodium citrate in 0.1 M Tris-HCl pH 7.4.
The mixture is centrifuged for 10 min. at 500 g. The supernatant is sucked off and the residue is resuspended in 250 gi of the same buffer.
At this step, the cells can be either deposited on a slide (30 to 40 41 of spermatozoa suspension on each slide) and treated by in situ hybridization with a biotinlabeled probe, or deposited on filters' and hybridizated by the technique of the dot-blot with a probe labeled with one of the radioactive nucleotides.
B. Subtreatement of the slides for the in situ hybridization.
After depositing the spermatozoa, the slides are dried in air and the spermatozoa are decondensed by the following procedure.
1) They are subjected to a hypotonic shock with the aid of a 0.08 M solution of potassium chloride for min. at room temperature. The spermatozoa are then fixed in a methanol/acetic acid mixture for 30 min.
To remove the activity of the endogenous peroxidase, the slides are treated with methanol 3.3 of H 2 0 2 for min. and then rinsed in absolute ethanol for 10 min., xylehe for 10 min. and absolute ethanol for 10 min.
7 c~ LI-4~- ~U 35 2) After drying in air, a solution of 40 U of papain (activated with 2 mmol of sodium sulfide in 0.1 14 Tris pH 8.6) (or proteinase K or trypsin) is deposited on each slide.
3) After incubation for 15 min. at 37*C, the slides are rinsed briefly in PBS and then incubated for min. at room temperature in a 0.1 M solution of Tris pH 8.6 containing 1 of DMSO or SDS and 40 mmol of an agent for reducing disulfide bridges, such as dithiothreitol, 8-mercaptoethanol or the like. The slides are subsquently washed for 3 times 5 min. in PBS and then dried in air. At this stage, the slides are ready for denaturation and in situ hybridization.
C. Technique of hybridization on slides The slides are incubated with 90 to 100 pl of hybridization liquid and covered with a plastic film (to prevent evaporation).
o After denaturation for 10 min. in an oven at 100°C, the slides are placed in a moist chamber and incubated at 42 0 C for 16 hours.
The final composition of the hybridization liquid a is as follows: 4 x SSC 1 mmol/l of EDTA 25 mmol/l of Tris-HCl pH 7.3 1 x Denhardt o o 10% of dextran o8 50% of deionized formamide Probe: 80 ng/ml of hybridization medium (1 x SSC 0.15 M NaC1, 0.015 M Na citrate) (1 x Denhardt 0.02% of BSA or 0.02% of skimmed milk powder, 0.02% of polyvinylpyrrolidond and 0.02% of Ficoll) After removal of the plastic film, the slides are washed successively in the following solutions: -36 2 x: SSC (30 minutes at room temperature), then 0.1 x SSC (30 minuter at 42 0 2 x SSC (15 minutes at room temperature) and finally PBS pH 7.4, to which 0.1% v/v of Triton x 100 and 0.5% of skimmed milk powder (Regilait) have been added.
D. Developing The slides, which are still moist after the excess fluid has been removed, are then incubated for 1 hour at 37°C with an antibiotin goat antibody or an antibiotin rabbit antibody. This antibody is sold in a form purified by affinity chromatography (Vector Laboratories ref. SP-3000) and is used in our tests as a 1:350 dilution in PBS pH 7.4 0.11 of Triton x 100 0.5% of skimmed milk powder.
After washing for 15 minutes at room temperature in PBS pH 7.4 0.1% of Triton x 100 0.5% (w/v) of skimmed milk powder, the slides are incubated for 0o 1 hour at 37°C with a conventional anti-goat rabbit S antibody or a conventional anti-rabbit goat antibody coupled to peroxidase (Biosys ref. BI 2403) as a 1:40 dilution in PBS pH 7.4 0.1% of Triton 0.5% of skimmed milk powder.
The slides are then washed for two times minutes in PBS pH 7.4, which this time contains 0.1% of Tween 20, and finally for 5 minutes in PBS pH 7.4.
They are incubated for 5 to 8 minutes at room temperature with a solution of diaminobenzidine (DAB SIGMA ref. D 8001) containing 0.5 mg/ml in PBS pH 7.4 containing 0.01% of H 2 0 2 The amount of precipitate formed by the reaction of the peroxidase with the DAB is increased by the successive precipitation of gold and silver salts in accordance with the process described by BURNS et al.
(Journal Clinical Pathology, 1985, 35, 1085-1092): r z.
37 In a first stage, 50 to 100 pl of a 2.5 mM solution of Na chloroaurate (NaAuCl 4 BDH ref. 30125 2R) are deposited on each slide and the slides are incubated for 5 min. at room temperature. After washing for min. in distilled water, the slides are incubated for min. at room temperature with 50 to 100 pl of a 0.1 M solution of Na sulfide (Na 2 S, SIGMA ref. S 2006), rinsed for 5 min. with distilled water and incubated for 4 to 8 minutes with 100 to 300 p 1 of silver reagent.
The composition of the silver reagent is as follows: A Na carbonate 0.24 mol/1 (SIGMA ref. S 4132) B1 Ammonium nitrate 13 mmol/l (SIGMA ref. A 9642) B2 Silver nitrate 6 mmol/1 (BDH ref. 303873N) B3 Dodecatungstosilicic acid 1.5 mmol/l (BDH ref. 305453R) B4 37% formaldehyde 0.6 pl/ml (SIGMA ref. F 1635) The silver reagent is prepared by successively mixing solutions B1, B2, B3 and B4, with stirring. The mixture obtained is added in a proportion of 1:1 to solution A and the reagent prepared in this way is used immediately.
After treatment with the silver reagent, the slides are washed with distilled H 0 for 15 minutes and 2 then in 1% acetic acid for 2 times 15 minutes and finally stained for 1 minute with a 1% solution of Pyronin Y (SIGMA ref. P 7017) in H20, rinsed for a few seconds in distilled water, dried in hot air and mounted Si 30 inDPX Altough the foregoing description has referred essentially to the function of the probe b.c.1.2. in determining the sex of bovine embryos, checking the presence of the Y chromosome in a population of spermatozoa and separating the said population into S* I Yd4 Il 38 two groups, respectively comprising the Y chromosome and the X chromosome, for their use in artificial insemination, it will easily be understood that this function can be extended to other animals insofar as they exhibit sequences of DNA specific for the male sex which are similar to those in said bovine embryos, likewise, the function of the probe b.c.1.2. as described above is given solely by way of a non-limiting example and can extend to the investigation of other sequences specific for the male sex.
As is apparent from the foregoing text, the invention is in no way limited to those methods of implementation, embodiments and methods of application which have now been described more explicitly on the contrary, it encompasses all the variants thereof which may occur to those skilled in the art, without departing from the framework or the scope of the present invention.
SN
0
Claims (17)
1. A molecular probe for DNA specific for the male genome of ruminants, especially of the subfamily of the bovines and particularly of the genus Bos said probe comprising a nucleic acid segment taken in the group consisting of a DNA segment of 49 base pairs length having the following nucleotide sequence, being designated by the name b.c.1.2 3' ATCAGTGCAGGGACCGAGATGTGCTCCAAGGAG1 o £TTATCGGCTGCTT a DNA segment containing at least 11 consecutive nucleotides of the said sequence, any nucleic acid segment having a sequence homologous or complementary to the sequence of the abovementioned DNA segments; the said probe hybridizes with a sequence being repeated at least 2000 times in the male genome of the Sgenus Bos, and further the said probe having a 20 hybridization profile, determined by hybridization with male genomic DNA digested by EcoRI, which reveals the presence of a band of the order of 7 kb which is specific for the male genome of the genus Bos.
2. A process for the preparation of a molecular probc accordinc o claim 1, said process comprising a first step in which female genomic DNA of a given j 0 species of ruminants, is cut by means of sonication into fragments of 200 to 550 base pairs (bp) and then mixed, in a proportion of the order of 100 1 with DNA fragments originating from the digestion of male genome of the same species of ruminants by endonuclease SAV3A, said fragments having sticky ends a second step, in which the mixture of DNA fragments resulting from the first step is extracted, in a manner known per se, with a phenol/chloroform/isoamyl alcohol mixture, precipitated with ethanol, denatured at 100°C 2^ y C_ _~L L_ i_ -,3f l. 40 and then reassociated at 68"C for 22 hours in a buffer containing 2 mmol/l of (NH 4 SO 4 50 mmol/l of sodium phosphate, pH 6.8 and 5 mmol/1 of EDTA a third step in which the reassociated double stranded DNA fragments resulting form the second step are inserted in a plasmid a fourth step in which the recombinant plasmids are used to transform EscherichiaColi cells which have been made highly competent and in which the transformed E.Coli cells are spread over an appropriate selective medium in order to select the clones bearing the recombinant plasmid a sixth step in which the recombinant plasmids isolated from the selected clones are digested by the endonuclease PvuII, the resulting fragments are labeled with at least one radioisotope, hybridized with male and female genomic DNA originating from ruminants digested by EcoRI and separated on by electrophoretic migration on agarose gel the PvuII fragment which hybridize specifically with a 7 kb EcoRI fragment of male bovine DNA is selected.
3. The process as claimed in claim 2, wherein the bacterial cells of Escherichia coli are made highly competent, prior to the insertion of the recombinant plasmids, by treatment for 10 minutes at 0°C with a medium comprising 10 mmol/l of K-Mes (pH 100 mmol/l of RbC12, 45 mmol/1 of MnCl 2 and 3 mmol/l of [Co(NH 3 6 C1 3
4. The process as claimed in claim 2, wherein the transformed bacteria are spread over a gelose medium 30 containing ampicillin and X-gal (or 5-bromo-4-chloro-3- indolyl-p-D-galactopyranoside at a low concentration in dimethylformamide, in order to select the recombinant clones. xV -<a7 \Ary 41 A process for the preparation of a molecular probe according to claim 1, wherein an oligonucleotide, which taken in the group consisting of -a DNA segment of 49 base pairs length having the following nucleotide sequence, being designated by the name b.c.1.2 3' ATCAGTGCAGGGACCGAGATGTGCTCCAAGGAGTGTTTATCGGCTGCTT a DNA segment containing at least 11 consecutive nucleotides of the said sequence, any nucleic acid segment having a sequence homologous or complementary to the sequence of the abovementionned DNA segments is synthesised by the phosphoramidite method in solid phase
6. The process as claimed in claim 5, wherein the r",oo synthesis of the oligonucleotide which forms part of the composition of the molecular probe is followed by a purification step which consists in separating out the oligonucleotide, associated with oligonucleotides of intermediate size, by electrophoresis on a polyacrylamide gel, and then identifying the band of the desired pure oligonucleotide with the aid of an aluminium foil coated with silica gel, which is fluorescent at 254 nm, cutting out this band and eluting the DNA in an appropriate S' solution, and then recovering the pure DNA synthesized. o" o 7, The process as claimed in claim 6, wherein the synthesized oligonucleotide is labeled with one or more j' 30 radioisotopes after purification.
8. Application of the molecular probe as claimed in claim 1 for determining the sex of ruminant embryos or fetuses, H' especially of the subfamily of the bovines and particularly of the genus Bos, wherein the said probe, hybridized to a filter prehybridized in an appropriate manner known per se, when the said probe is reassociated 42 with genomic DNA of said ruminants male and female transferred beforehand onto an appropriate filter after having been isolated by electrophoresis on agarose gel, hybridizes to the male genomic DNA and this hybridization is demonstrated by autoradiography and/or by means of a non-radioactive probe, by the presence of hybridization signals in the form of a specific 7 kb band.
9. Application as claimed in claim 8, wherein the DNA to be recognized is contained in lymphocytes of the above- mentioned ruminants. Application as claimed in claim 8, wherein the DNA to be recognized is contained in cells issued from amniotic or allantoidic fluid or from chorionic villosities of the above-mentioned ruminants.
11. Application as claimed in claim 8, wherein cells or similar containing the DNA to be recognized are deposited on a membrane (dot-blot) or an appropriate filter.
12. Application as claimed in claim 8, wherein the DNA to be recognized is contained in the Y chromosome of the said ruminants, observed at the metaphase stage, in which a case the sex is determined by so-called in situ hybridization.
13. Application as claimed in claim 8, wherein the DNA to be recognized is contained in nuclei of cells of the said ruminants at the interphase stage, in which case the sex is determined by so-called in situ hybridization. 0° 14. Application as claimed in claim 8, wherein in the in 0 situ hybridization, a biopsy of 5 to 20 cells from an embryo of said ruminants is brought into contact with the 30 molecular probe for effecting the labeling of said cells by hybridization with said probe labeled with one or more radioisotopes or with a non-radioactive probe, then the hybridization is revealed by an appropriated cytoimmuno- chemical method.
15. Application of the molecular probe as claimed in claim 1 for determining the sex of ruminant embryos or 43 j i fetuses, especially of the subfamily of the bovines and particularly of the genus Bos, wherein the said probe, hybridized to a filter prehybridized in an appropriate manner known per se, when the said probe is reassociated with genomic DNA of said ruminants male and female transferred beforehand onto an appropriate filter after having been isolated by electrophoresis on agarose gel, hybridizes to the male genomic DNA and this hybridization is demonstrated by autoradiography and/or by means of a non-radioactive probe, by the presence of hybridization signals in the form of a specific 7 kb band.
16. Application as claimed in claim 15, wherein the DNA to be recognized is contained in lymphocytes of the above-mentioned ruminants.
17. Application as claimed in claim 15, wherein the DNA to be recognized is contained in cells issued from amniotic or allantoidic fluid or from chorionic villosities of the above-mentioned ruminants.
18. Application as claimed in claim 15, wherein cells or similar containing the DNA to be recognized are deposited on a membrane (dot-blot) or an appropriate filter.
19. Application as claimed in claim 15, wherein the DNA to be recognized is contained in the Y chromosome of the said ruminants, observed at the metaphase stage, in which case the sex is determining by so-called in situ hybridization. o.o. 20. Application as claimed in claim 15, wherein the DNA to be recognized is contained in nuclei of cells of the said ruminants at the interphase stage, in which case the sex is determining by so-called in situ hybridization.
21. Application as claimed in claim 15, wherein in the in situ hybridization, a biopsy of 5 to 20 cells from an embryo of said ruminants is brought into contact with the molecular probe for effecting the labeling of said cells by hybridization with said probe labeled with one or more radioisotopes or with a non-radioactive probe, then the 44 Si i'
44- hybridization is revealed by an appropriated cytoimmuno- chemical method. 22. A process for directly and immediately checking the proportion of spermatozoa bearing the Y chromosome in a population of spermatozoa of ruminants, especialy of the subfamily of the bovines and more particularly of the genus Bos, wherein the spermatozoa of the said population are brought into contact with a probe for DNA according to claim 1 in order to label the said spermatozoa by hybridization with the said probe suitably labeled and the hybridized spermatozoa are then revealed by an appropriated cytoimmunochemical method. 23. The checking process as claimed in claim 22, wherein the hybridization of the spermatozoa with the molecular probe for specific DNA is effected in situ directly with the spermatozoa. 24. The checking process as claimed in claim 22, wherein the hybridization is effected between the molecular probe for specific DNA and the DNA isolated from spermatozoa of ruminants of the genus Bos. The checking process as claimed in claim 24, wherein the spermatozoa are subjected, prior to the hybridization step, to a chemical decondensation process comprising essentially three steps, namely hypotonic shock, proteolytic digestion and reduction of the disulfide bridges. o0,o 26. A process for directly and immediately checking the 0: proportion of spermatozoa bearing the Y chromosome in a population of spermatozoa of ruminants of the subfamily of the bovines and more particularly of the genus Bos, wherein the spermatozoa of the said population are brought into contact with a probe for DNA according to claim i, in order to label the said spermatozoa by hybridization with the said probe suitably labeled and the hybridized spermatozoa are then revealed by an appropriated cytoimmunochemical method. I A 1 45 27. The checking process as claimed in claim 26, wherein the hybridization of the spermatozoa with the molecular probe for specific DNA is effected in situ directly with the spermatozoa. 28. The checking process as claimed in claim 26, wherein the hybridization is effected between the molecular probe for specific DNA and the DNA isolated from spermatozoa of ruminants of the genus Bos. 29. The checking process as claimed in claim 28, wherein the spermatozoa are subjected, prior to the hybridization step, to a chemical d-condensation process comprising essentially three steps, namely hypotonic shock, proteolytic digestion and reduction of the disulfide bridges. 30. The molecular probe for DNA specific for the male genome of ruminants, especially of the genus Bos, as claimed in claim 1, which is labeled with one or more radioisotopes. 31. The molecular probe for DNA specific for the male 20 genome of ruminants, especially of the genus Bos, as claimed in claim 1, which is a non-radioactive probe. DATED this 21st day of February 1990 INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) INSTITUT PASTEUR COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA) By Their Patent Attorneys: GRIFFITH HACK CO Fellows Institute of Patena Attorneys of Australia (2?
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8602811A FR2595100B1 (en) | 1986-02-28 | 1986-02-28 | MOLECULAR PROBES OF DNA SPECIFIC TO THE MALE GENOM OF MAMMALS, ESPECIALLY OF THE GENUS BOS, HAVING SEQUENCES OF DNA SPECIFIC TO THE MALE SEX, METHOD FOR PREPARING SUCH PROBES AND METHOD FOR DETERMINING THE SEX OF EMBRYOS AND FETUS OF MAMMALS, USING THESE PROBES |
| FR8602811 | 1986-02-28 | ||
| FR8612616A FR2603701B2 (en) | 1986-02-28 | 1986-09-09 | APPLICATIONS OF MOLECULAR DNA PROBES OF THE MALE MAMMALIAN GENOME, ESPECIALLY OF THE GENUS BOS, FOR THE CONTROL OF THE PRESENCE OF CHROMOSOME Y IN A POPULATION OF SPERMATOZOIDES AND IN THE SEPARATION OF SPERMATOZOIDS INTO TWO POPULATIONS OF SPERMATOZOID AND RESPECTIVE CARRIERS CHROMOSOME X FOR THEIR USE FOR ARTIFICIAL INSEMINATION |
| FR8612616 | 1986-09-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6920387A AU6920387A (en) | 1987-09-03 |
| AU596642B2 true AU596642B2 (en) | 1990-05-10 |
Family
ID=26225052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU69203/87A Ceased AU596642B2 (en) | 1986-02-28 | 1987-02-24 | Molecular probes, process for preparation thereof, and applications including their use for determining the sex of embryos |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0235046B1 (en) |
| AU (1) | AU596642B2 (en) |
| CA (1) | CA1312565C (en) |
| DE (1) | DE3786181T2 (en) |
| ES (1) | ES2042591T3 (en) |
| FR (1) | FR2603701B2 (en) |
| IN (1) | IN167981B (en) |
| NZ (1) | NZ219431A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614494B2 (en) * | 1986-08-12 | 1991-09-05 | Australian National University, The | Sex determination in ruminants using y-chromosome specific polynucleotides |
| AU621556B2 (en) * | 1987-08-27 | 1992-03-19 | Commissariat A L'energie Atomique | Specific dna molecular probes for bos-type male genome |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8716367D0 (en) * | 1987-07-10 | 1987-08-19 | Reeders S T | Genetic identification |
| US5328827A (en) * | 1987-08-27 | 1994-07-12 | Institut National De La Recherche Agronomique - Inra | Specific DNA molecular probes for Bos-type male genome |
| WO1989002440A2 (en) * | 1987-09-21 | 1989-03-23 | Whitehead Institute For Biomedical Research | Y-specific dna hybridization probes and uses therefor |
| EP0338067A4 (en) * | 1987-10-02 | 1991-05-02 | Microprobe Corporation | Human papillomavirus type diagnosis with nucleotide probes |
| ATE139265T1 (en) * | 1988-01-29 | 1996-06-15 | Advanced Riverina Holdings | DETERMINATION OF SEX IN RUMINANTS USING GAMMA CHROMOSOME SPECIFIC POLYNUCLEOTIDES |
| FR2635116B1 (en) * | 1988-08-08 | 1990-11-02 | Georges Michel | PROCESS FOR THE DETERMINATION OF THE SEX OF RUMINANT EMBRYOS, KIT OR NECESSARY FOR THE IMPLEMENTATION OF THE PROCESS |
| FR2648151B1 (en) * | 1989-06-08 | 1991-12-20 | Michel Georges | MINISATELLITE CATTLE SPECIFIC TO CHROMOSOME Y OF BOVINES |
| US5055393A (en) * | 1989-06-13 | 1991-10-08 | Salk Institute Biotechnology/Industrial Associates, Inc. | Prenatal sex determination of bovine cells using male-specific oligonucleotides |
| DE19959751A1 (en) * | 1999-12-11 | 2001-06-13 | Hans Rudolf Fries | New bovine genomic DNA sequences, useful for establishing genetic signatures, e.g. for breeding control, contain specific variable positions |
| DE102008033570B4 (en) * | 2008-07-15 | 2010-09-30 | Masterrind Gmbh | Method for cell identification and cell sorting |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8007182A (en) * | 1980-12-18 | 1982-07-01 | Yale University | Method for cloning genes |
| AU5956186A (en) * | 1985-05-31 | 1986-12-24 | Salk Institute Biotechnology/Industrial Associates, Inc., The | Nucleic acid probes for prenatal sexing |
| AU4727185A (en) * | 1985-08-20 | 1987-03-10 | Apothekernes Laboratorium A.S. | Photoimmune detection of dna and rna |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4448767A (en) * | 1977-10-11 | 1984-05-15 | Sumar Corporation | Preparation of monospecific male-specific antibody and the use thereof for increasing the percentage of mammalian offspring of either sex |
| EP0120854A4 (en) * | 1982-10-05 | 1985-06-10 | Genetic Engineering Inc | Method of treating collected mammal semen and separating sperm into x and y components. |
| FR2566911A1 (en) * | 1984-06-29 | 1986-01-03 | Pasteur Institut | PROBE AND METHOD FOR THE DIAGNOSIS OF THE SEX OF A HUMAN EMBRYO |
-
1986
- 1986-09-09 FR FR8612616A patent/FR2603701B2/en not_active Expired - Lifetime
-
1987
- 1987-02-24 AU AU69203/87A patent/AU596642B2/en not_active Ceased
- 1987-02-25 CA CA 530626 patent/CA1312565C/en not_active Expired - Fee Related
- 1987-02-27 IN IN150/CAL/87A patent/IN167981B/en unknown
- 1987-02-27 ES ES87400434T patent/ES2042591T3/en not_active Expired - Lifetime
- 1987-02-27 EP EP87400434A patent/EP0235046B1/en not_active Expired - Lifetime
- 1987-02-27 DE DE19873786181 patent/DE3786181T2/en not_active Expired - Fee Related
- 1987-02-27 NZ NZ21943187A patent/NZ219431A/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8007182A (en) * | 1980-12-18 | 1982-07-01 | Yale University | Method for cloning genes |
| AU5956186A (en) * | 1985-05-31 | 1986-12-24 | Salk Institute Biotechnology/Industrial Associates, Inc., The | Nucleic acid probes for prenatal sexing |
| AU4727185A (en) * | 1985-08-20 | 1987-03-10 | Apothekernes Laboratorium A.S. | Photoimmune detection of dna and rna |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614494B2 (en) * | 1986-08-12 | 1991-09-05 | Australian National University, The | Sex determination in ruminants using y-chromosome specific polynucleotides |
| AU621556B2 (en) * | 1987-08-27 | 1992-03-19 | Commissariat A L'energie Atomique | Specific dna molecular probes for bos-type male genome |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0235046A1 (en) | 1987-09-02 |
| NZ219431A (en) | 1989-04-26 |
| ES2042591T3 (en) | 1993-12-16 |
| AU6920387A (en) | 1987-09-03 |
| DE3786181D1 (en) | 1993-07-22 |
| FR2603701A2 (en) | 1988-03-11 |
| EP0235046B1 (en) | 1993-06-16 |
| CA1312565C (en) | 1993-01-12 |
| DE3786181T2 (en) | 1993-09-23 |
| IN167981B (en) | 1991-01-19 |
| FR2603701B2 (en) | 1990-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU596642B2 (en) | Molecular probes, process for preparation thereof, and applications including their use for determining the sex of embryos | |
| Matsuda et al. | Application of fluorescence in situ hybridization in genome analysis of the mouse | |
| Saumweber et al. | Monoclonal antibodies against chromosomal proteins of Drosophila melanogaster: establishment of antibody producing cell lines and partial characterization of corresponding antigens | |
| Kawata et al. | Transcriptional control of HLA-A, B, C antigen in human placental cytotrophoblast isolated using trophoblast-and HLA-specific monoclonal antibodies and the fluorescence-activated cell sorter. | |
| Trask et al. | Detection of DNA sequences in nuclei in suspension by in situ hybridization and dual beam flow cytometry | |
| Covone et al. | Analysis of peripheral maternal blood samples for the presence of placenta‐derived cells using Y‐specific probes and McAb H315 | |
| Lewis et al. | Sensitive in situ hybridisation technique using biotin-streptavidin-polyalkaline phosphatase complex. | |
| Ochs | Methods used to study structure and function of the nucleolus | |
| JPS61185200A (en) | Immobilization of nucleic acid | |
| JP2009118853A (en) | In situ hybridization for detecting specific nucleic acid sequence in eukaryotic sample | |
| JPH08500967A (en) | DNA sequences encoding human A1, A2a and A2b adenosine receptors | |
| Gledhill | Gender preselection: Historical, technical, and ethical perspectives | |
| Mukherjee et al. | Absolute copy number differences of Y chromosomal genes between crossbred (Bos taurus× Bos indicus) and Indicine bulls | |
| EP0944829B1 (en) | Selective lysis of cells | |
| Rejduch et al. | 60, XY/60, XX chimerism in the germ cell line of mature bulls born in heterosexual twinning | |
| EP0276287B1 (en) | Sex determination in ruminants using y-chromosome specific polynucleotides | |
| WO1995009245A1 (en) | Methods for detecting and analyzing individual rare cells in a population | |
| Yamada et al. | Induction of differentiation of mouse myeloid leukemia cells by poly (ADP-ribose) | |
| Wyrobek et al. | Aneuploidy in late‐step spermatids of mice detected by two‐chromosome fluorescence in situ hybridization | |
| Vinores et al. | Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen. | |
| Guttenbach et al. | Interphase chromosome arrangement in Sertoli cells of adult mice | |
| US5418133A (en) | Sex determination in cattle, sheep and goats using y-chromosome polynucleotides | |
| Wasicek et al. | Occurrence of antibodies to single-stranded DNA in ANA negative patients | |
| AU621556B2 (en) | Specific dna molecular probes for bos-type male genome | |
| US5328827A (en) | Specific DNA molecular probes for Bos-type male genome |